Early / Compassionate Use

Early access / compassionate

If you wish to implement an Early Access or Compassionate study, the experts at RCTs will support and advise you, whether on the regulatory side, the design of study documents, the organisation of logistics, pharmacovigilance management, data management via a digital solution dedicated to the specific features of these studies, data analysis or the drafting of study reports for the ANSM.

We have already accompanied them

Early access and real word data: the example of the DARATUMUMAB cohort ATU

Our experts are available for you

Study Director - Member of the AFCROs MD working group

Next expertise

Pre-Authorization Studies Learn more

Do you need a strong
partner to rely on ?


Let’s talk about it